Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.

Creators: BOCCARDO, FRANCESCO; AMADORI D; GUGLIELMINI P; SISMONDI P; FARRIS A; AGOSTARA B; GAMBI A; CATALANO G; FAEDI M; RUBAGOTTI, ALESSANDRA

Others:: Boccardo, Francesco; Amadori, D; Guglielmini, P; Sismondi, P; Farris, A; Agostara, B; Gambi, A; Catalano, G; Faedi, M; Rubagotti, Alessandra

Additional details